Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)1575-1582
Number of pages8
JournalCurrent Oncology
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 2022

ASJC Scopus Subject Areas

  • Oncology

Keywords

  • Carfilzomib
  • Multiple myeloma
  • Pomalidomide
  • Relapsed/refractory
  • Sequence

Fingerprint

Dive into the research topics of 'Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database'. Together they form a unique fingerprint.

Cite this